Ginger Nicol, MD
Enriched profileProfessor of Psychiatry · Washington University in St Louis School of Medicine
Ginger Nicol is Professor of Psychiatry at Washington University in St Louis School of Medicine. OpenAlex indexes 140 publications with 3,001 citations (h-index 25); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 27 Oct 2026
Ginger Nicol, MD, is Professor of Psychiatry at Washington University in St Louis School of Medicine. The public record shows 140 publications with 3,001 citations (h-index 25), centered on Schizophrenia research and treatment, Treatment of Major Depression, Digital Mental Health Interventions. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 1 companies, 6 NIH-funded awards (2011–2026).
- Most recent indexed publication: 2026 · Health affairs scholar
- Top research focus: Schizophrenia research and treatment
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 23 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 43.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Digital Intervention to Promote Medical Trainee Well-being (OptimalWork Pilot)
Sponsor: Washington University School of Medicine
- Psilocybin for Major Depressive Disorder
Sponsor: Washington University School of Medicine
- Transgender Estradiol Affirming Therapy
Sponsor: Washington University School of Medicine
Industry payments
Updated 26 Oct 2026
1 company reported payments to CMS in program years 2022–2022. These are public disclosures, not judgments. The latest:
- Alkermes, Inc.Program year20221 payment
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Aminoketone100%Bupropion Xl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 26 Oct 2026
6 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)
Washington University
FY2026$1,557,997UH3MH137353 - Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)
Washington University
FY2026$529,185UH3MH137353 - Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic risk
Washington University
FY2025$606,127R01MH122686
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- "Am I a candidate for magic mushrooms?" A mystery shopper study of Oregon psilocybin service centers.
Health affairs scholar
Article2026 - Brain-cognition relationships and treatment outcome in treatment-resistant late-life depression.
Nature communications
Article2026 - Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine.
Neuropsychopharmacology
Review2026
Most-cited works
by citation count (OpenAlex)- 01Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19Article495 citations2020
- 02Psilocybin desynchronizes the human brainArticle273 citations2024
- 03Psychedelic Drug Legislative Reform and Legalization in the USArticle181 citations2022
- 04
- 05Effects of Mindfulness Training and Exercise on Cognitive Function in Older AdultsArticle161 citations2022
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
psychiatry.wustl.edu/people/dr-ginger-e-nicol
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatry.wustl.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- Child Fellowship Mentoring Award
Washington University School of Medicine, Department of Psychiatry
2019verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
Secondary affiliations
appointments beyond the home institution- Co-Director
Healthy Mind Lab
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗ - Founding Director
WashU Center for Holistic Interdisciplinary Research in Psychedelics (CHIRP)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatry.wustl.edu ↗
Media & interviews
press, podcasts and appearances- Life Beyond Loss podcast
Episode 13: "WashU's Psychedelic Research - Seeing the Mind in Real Time"
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lifebeyondloss.podbean.com ↗ - Healthy Mind Lab
"Psychedelic Drugs for Mental Health Treatments at Wash U-St. Louis On the Air interview with Ginger Nicol"
2022verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthymind.wustl.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania